Literature DB >> 24080483

Telomere lengths at birth in trisomies 18 and 21 measured by Q-FISH.

Ken-Ichi Nakamura1, Naoshi Ishikawa, Naotaka Izumiyama, Junko Aida, Mie Kuroiwa, Naoki Hiraishi, Mutsunori Fujiwara, Atsushi Nakao, Tadashi Kawakami, Steven S S Poon, Masaaki Matsuura, Motoji Sawabe, Tomio Arai, Kaiyo Takubo.   

Abstract

Trisomies 18 and 21 are genetic disorders in which cells possess an extra copy of each of the relevant chromosomes. Individuals with these disorders who survive birth generally have a shortened life expectancy. As telomeres are known to play an important role in the maintenance of genomic integrity by protecting the chromosomal ends, we conducted a study to determine whether there are differences in telomere length at birth between individuals with trisomy and diploidy, and between trisomic chromosomes and normal chromosomes. We examined samples of peripheral blood lymphocytes (PBLs) from 31 live neonates (diploidy: 10, trisomy 18: 10, trisomy 21: 11) and estimated the telomere length of each chromosome arm using Q-FISH. We observed that the telomeres of trisomic chromosomes were neither shorter nor longer than the mean telomere length of chromosomes as a whole among subjects with trisomies 18 and 21 (intra-cell comparison), and we were unable to conclude that there were differences in telomere length between 18 trisomy and diploid subjects, or between 21 trisomy and diploid subjects (inter-individual comparison). Although it has been reported that telomeres are shorter in older individuals with trisomy 21 and show accelerated telomere shortening with age, our data suggest that patients with trisomies 18 and 21 may have comparably sized telomeres. Therefore, it would be advisable for them to avoid lifestyle habits and characteristics such as obesity, cigarette smoking, chronic stress, and alcohol intake, which lead to marked telomere shortening.
© 2013.

Entities:  

Keywords:  4′, 6-diamidino-2-phenylindole; CENP1; Cy3-labeled (CCCTAA)3 peptide nucleic acid probe; DAPI; Down syndrome; FITC-labeled CTTCGTTGGAAACGGGGT peptide nucleic acid probe; PBL; PDL; PNA; Q-FISH; TFU; TRF; Telo C; Telomere; Trisomy 18; Trisomy 21; kbp; kilobase pairs; peptide nucleic acid; peripheral blood lymphocyte; population doubling level; quantitative fluorescence in situ hybridization; telomere fluorescence unit; terminal restriction fragment

Mesh:

Year:  2013        PMID: 24080483     DOI: 10.1016/j.gene.2013.09.086

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

1.  Telomere shortening in Down syndrome patients--when does it start?

Authors:  Aleksandra Gruszecka; Przemysław Kopczyński; Dorota Cudziło; Natalia Lipińska; Aleksandra Romaniuk; Wojciech Barczak; Natalia Rozwadowska; Ewa Totoń; Błażej Rubiś
Journal:  DNA Cell Biol       Date:  2015-03-18       Impact factor: 3.311

2.  Congenital Aneuploidy in Klinefelter Syndrome with B-Cell Acute Lymphoblastic Leukemia Might Be Associated with Chromosomal Instability and Reduced Telomere Length.

Authors:  Eigil Kjeldsen
Journal:  Cancers (Basel)       Date:  2022-05-06       Impact factor: 6.575

3.  Application of improved single blastomere fixation technique in preimplantation genetic diagnosis.

Authors:  Guanling Yu; Shuiying Ma; Yueting Zhu; Yujin Liu; Haozhen Zhang; Keliang Wu; Aijun Hao
Journal:  Cytotechnology       Date:  2020-03-31       Impact factor: 2.058

4.  Longitudinal telomere length and body composition in healthy term-born infants during the first two years of life.

Authors:  Kirsten S de Fluiter; Veryan Codd; Matthew Denniff; Gerthe F Kerkhof; Inge A L P van Beijsterveldt; Laura M Breij; Nilesh J Samani; Marieke Abrahamse-Berkeveld; Anita C S Hokken-Koelega
Journal:  PLoS One       Date:  2021-02-02       Impact factor: 3.240

5.  Can telomere shortening be the main indicator of non-viable fetus elimination?

Authors:  Nataliya Huleyuk; Iryna Tkach; Danuta Zastavna; Miroslaw Tyrka
Journal:  Mol Cytogenet       Date:  2018-01-25       Impact factor: 2.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.